Prediction of hepatotoxicity for drugs using human pluripotent stem cell-derived hepatocytes

Jong Hyun Kim, Min Wang, Jaehun Lee, Han Jin Park, Chungseong Han, Hee Su Hong, Jeong Seong Kim, Geun Ho An, Kijung Park, Hee Kyung Park, Shi Feng Zhu, Xiao Bo Sun, Jong-Hoon Kim, Dong Hun Woo

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Drug-induced liver toxicity is a main reason for withdrawals of new drugs in late clinical phases and post-launch of the drugs. Thus, hepatotoxicity screening of drug candidates in pre-clinical stage is important for reducing drug attrition rates during the clinical development process. Here, we show commercially available hepatocytes that could be used for early toxicity evaluation of drug candidates. From our hepatic differentiation technology, we obtained highly pure (≥98%) hepatocytes from human embryonic stem cells (hESCs) having mature phenotypes and similar gene expression profiles with those of primary human tissues. Furthermore, we optimized 96-well culture condition of hESC-derived hepatocytes suitable for toxicity tests in vitro. To this end, we demonstrated the efficacy of our optimized hepatocyte model for predicting hepatotoxicity against the Chinese herbal medicines and showed that toxicity patterns from our hepatocyte model was similar to those of human primary cultured hepatocytes. We conclude that toxicity test using our hepatocyte model could be a good alternative cell source for pre-clinical study to predict potential hepatotoxicity in drug discovery industries.

Original languageEnglish
Pages (from-to)1-14
Number of pages14
JournalCell Biology and Toxicology
DOIs
Publication statusAccepted/In press - 2017 Apr 5

Fingerprint

Pluripotent Stem Cells
Stem cells
Hepatocytes
Toxicity
Pharmaceutical Preparations
Toxicity Tests
Preclinical Drug Evaluations
Drug Evaluation
Herbal Medicine
Liver
Drug Industry
Drug Discovery
Drug-Related Side Effects and Adverse Reactions
Transcriptome
Cell culture
Gene expression
Screening
Tissue
Technology
Phenotype

Keywords

  • Drug screening
  • Hepatocytes
  • Human embryonic stem cells
  • Toxicity test

ASJC Scopus subject areas

  • Toxicology
  • Cell Biology
  • Health, Toxicology and Mutagenesis

Cite this

Kim, J. H., Wang, M., Lee, J., Park, H. J., Han, C., Hong, H. S., ... Woo, D. H. (Accepted/In press). Prediction of hepatotoxicity for drugs using human pluripotent stem cell-derived hepatocytes. Cell Biology and Toxicology, 1-14. https://doi.org/10.1007/s10565-017-9392-y

Prediction of hepatotoxicity for drugs using human pluripotent stem cell-derived hepatocytes. / Kim, Jong Hyun; Wang, Min; Lee, Jaehun; Park, Han Jin; Han, Chungseong; Hong, Hee Su; Kim, Jeong Seong; An, Geun Ho; Park, Kijung; Park, Hee Kyung; Zhu, Shi Feng; Sun, Xiao Bo; Kim, Jong-Hoon; Woo, Dong Hun.

In: Cell Biology and Toxicology, 05.04.2017, p. 1-14.

Research output: Contribution to journalArticle

Kim, JH, Wang, M, Lee, J, Park, HJ, Han, C, Hong, HS, Kim, JS, An, GH, Park, K, Park, HK, Zhu, SF, Sun, XB, Kim, J-H & Woo, DH 2017, 'Prediction of hepatotoxicity for drugs using human pluripotent stem cell-derived hepatocytes', Cell Biology and Toxicology, pp. 1-14. https://doi.org/10.1007/s10565-017-9392-y
Kim, Jong Hyun ; Wang, Min ; Lee, Jaehun ; Park, Han Jin ; Han, Chungseong ; Hong, Hee Su ; Kim, Jeong Seong ; An, Geun Ho ; Park, Kijung ; Park, Hee Kyung ; Zhu, Shi Feng ; Sun, Xiao Bo ; Kim, Jong-Hoon ; Woo, Dong Hun. / Prediction of hepatotoxicity for drugs using human pluripotent stem cell-derived hepatocytes. In: Cell Biology and Toxicology. 2017 ; pp. 1-14.
@article{72a74c0697c94b428543b21eae7b53b9,
title = "Prediction of hepatotoxicity for drugs using human pluripotent stem cell-derived hepatocytes",
abstract = "Drug-induced liver toxicity is a main reason for withdrawals of new drugs in late clinical phases and post-launch of the drugs. Thus, hepatotoxicity screening of drug candidates in pre-clinical stage is important for reducing drug attrition rates during the clinical development process. Here, we show commercially available hepatocytes that could be used for early toxicity evaluation of drug candidates. From our hepatic differentiation technology, we obtained highly pure (≥98{\%}) hepatocytes from human embryonic stem cells (hESCs) having mature phenotypes and similar gene expression profiles with those of primary human tissues. Furthermore, we optimized 96-well culture condition of hESC-derived hepatocytes suitable for toxicity tests in vitro. To this end, we demonstrated the efficacy of our optimized hepatocyte model for predicting hepatotoxicity against the Chinese herbal medicines and showed that toxicity patterns from our hepatocyte model was similar to those of human primary cultured hepatocytes. We conclude that toxicity test using our hepatocyte model could be a good alternative cell source for pre-clinical study to predict potential hepatotoxicity in drug discovery industries.",
keywords = "Drug screening, Hepatocytes, Human embryonic stem cells, Toxicity test",
author = "Kim, {Jong Hyun} and Min Wang and Jaehun Lee and Park, {Han Jin} and Chungseong Han and Hong, {Hee Su} and Kim, {Jeong Seong} and An, {Geun Ho} and Kijung Park and Park, {Hee Kyung} and Zhu, {Shi Feng} and Sun, {Xiao Bo} and Jong-Hoon Kim and Woo, {Dong Hun}",
year = "2017",
month = "4",
day = "5",
doi = "10.1007/s10565-017-9392-y",
language = "English",
pages = "1--14",
journal = "Cell Biology and Toxicology",
issn = "0742-2091",
publisher = "Springer Netherlands",

}

TY - JOUR

T1 - Prediction of hepatotoxicity for drugs using human pluripotent stem cell-derived hepatocytes

AU - Kim, Jong Hyun

AU - Wang, Min

AU - Lee, Jaehun

AU - Park, Han Jin

AU - Han, Chungseong

AU - Hong, Hee Su

AU - Kim, Jeong Seong

AU - An, Geun Ho

AU - Park, Kijung

AU - Park, Hee Kyung

AU - Zhu, Shi Feng

AU - Sun, Xiao Bo

AU - Kim, Jong-Hoon

AU - Woo, Dong Hun

PY - 2017/4/5

Y1 - 2017/4/5

N2 - Drug-induced liver toxicity is a main reason for withdrawals of new drugs in late clinical phases and post-launch of the drugs. Thus, hepatotoxicity screening of drug candidates in pre-clinical stage is important for reducing drug attrition rates during the clinical development process. Here, we show commercially available hepatocytes that could be used for early toxicity evaluation of drug candidates. From our hepatic differentiation technology, we obtained highly pure (≥98%) hepatocytes from human embryonic stem cells (hESCs) having mature phenotypes and similar gene expression profiles with those of primary human tissues. Furthermore, we optimized 96-well culture condition of hESC-derived hepatocytes suitable for toxicity tests in vitro. To this end, we demonstrated the efficacy of our optimized hepatocyte model for predicting hepatotoxicity against the Chinese herbal medicines and showed that toxicity patterns from our hepatocyte model was similar to those of human primary cultured hepatocytes. We conclude that toxicity test using our hepatocyte model could be a good alternative cell source for pre-clinical study to predict potential hepatotoxicity in drug discovery industries.

AB - Drug-induced liver toxicity is a main reason for withdrawals of new drugs in late clinical phases and post-launch of the drugs. Thus, hepatotoxicity screening of drug candidates in pre-clinical stage is important for reducing drug attrition rates during the clinical development process. Here, we show commercially available hepatocytes that could be used for early toxicity evaluation of drug candidates. From our hepatic differentiation technology, we obtained highly pure (≥98%) hepatocytes from human embryonic stem cells (hESCs) having mature phenotypes and similar gene expression profiles with those of primary human tissues. Furthermore, we optimized 96-well culture condition of hESC-derived hepatocytes suitable for toxicity tests in vitro. To this end, we demonstrated the efficacy of our optimized hepatocyte model for predicting hepatotoxicity against the Chinese herbal medicines and showed that toxicity patterns from our hepatocyte model was similar to those of human primary cultured hepatocytes. We conclude that toxicity test using our hepatocyte model could be a good alternative cell source for pre-clinical study to predict potential hepatotoxicity in drug discovery industries.

KW - Drug screening

KW - Hepatocytes

KW - Human embryonic stem cells

KW - Toxicity test

UR - http://www.scopus.com/inward/record.url?scp=85017171294&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017171294&partnerID=8YFLogxK

U2 - 10.1007/s10565-017-9392-y

DO - 10.1007/s10565-017-9392-y

M3 - Article

C2 - 28382404

AN - SCOPUS:85017171294

SP - 1

EP - 14

JO - Cell Biology and Toxicology

JF - Cell Biology and Toxicology

SN - 0742-2091

ER -